SEC Form 4 · accession 0001547522-16-000320
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Scott Tomsche
Director
Period of report
Nov 7, 2016
Accepted (ET)
Nov 8, 2016 · 11:08 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per shareF1 | Nov 7, 2016 | P | 4,000 | $5.19 | A | 70,789 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1(1) This figure includes 2,322 shares of common stock held by immediate family member of Dr. Tomsche.